Missing data in model-based pharmacometric applications: points to consider.
about
Population pharmacokinetics of bevacizumab in cancer patients with external validationComparison of methods for handling missing covariate data.Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working groupCombining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a β regression meta-analysis.Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.Performance of nonlinear mixed effects models in the presence of informative dropout.A novel metric to assess the clinical utility of a drug in the presence of efficacy and dropout information.Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trials.Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory.
P2860
Q26779580-5376E593-714E-4211-B6B2-E4A5374EF49BQ30666096-663339DE-AEA6-4A8D-96B4-E34B68C88AADQ30779044-CC64B7F8-B502-4BED-B7CD-60B6802CD011Q34347396-116922DB-88D0-4D67-8B82-A5DE0FF0F79BQ38859853-A3998DCF-D53B-4F4B-91EE-1048AF35BD62Q43096322-42B79522-49C3-4251-9915-E8F55D492B6BQ44271163-74447CBD-3E43-448C-97F5-EAE5AE0D1D37Q48017570-094B02A9-91E5-49A9-BE4A-AC5DC35DF7B9Q49178301-325848ED-23EF-4F36-92A6-1ECAC4A8E7AEQ55362523-11D78668-4088-4BA5-B13F-840B8BAC35BA
P2860
Missing data in model-based pharmacometric applications: points to consider.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Missing data in model-based pharmacometric applications: points to consider.
@ast
Missing data in model-based pharmacometric applications: points to consider.
@en
type
label
Missing data in model-based pharmacometric applications: points to consider.
@ast
Missing data in model-based pharmacometric applications: points to consider.
@en
prefLabel
Missing data in model-based pharmacometric applications: points to consider.
@ast
Missing data in model-based pharmacometric applications: points to consider.
@en
P2093
P2860
P356
P1476
Missing data in model-based pharmacometric applications: points to consider
@en
P2093
Daniel F Heitjan
Jae Eun Ahn
James A Rogers
Marc R Gastonguay
Patanjali Ravva
P2860
P304
P356
10.1177/0091270010378409
P433
P577
2010-09-01T00:00:00Z